How would you counsel a patient concerned about receiving IMRT rather than IMPT for oropharyngeal cancer?

I would tell the patient there is absolutely no concern at all with IMRT, and it is a very well-established SOC. I am personally unclear about the OS benefit with IMPT, as it was pointed out, unexpected. It is unusual to see no difference in PFS and no tox difference, and yet there is an OS differen...

I would inform the patient that IMRT remains a well-established standard of care and is my first choice for definitive radiotherapy for oropharyngeal cancer. The reported survival difference in that trial was based on very few events and occurred in a study with significant crossover, as well as an ...

Treatment at a center of excellence with high volumes and/or a well-trained, experienced radiation oncologist and team is more important than proton or photon discussion, IMHO.

I agree with @Dr. First Last and @Dr. First Last.